Search results
Author(s):
Steve Attanasio
,
Raed Al Dallow
,
Sandeep Nathan
Added:
3 years ago
While acute coronary syndromes inclusive of ST-elevation myocardial infarction (STEMI) have been described in patients with polycythemia vera (PCV), optimal pharmacologic and interventional management strategies in the setting of drastically elevated platelet counts remain unclear.1 To our knowledge this is the first reported case of STEMI with massive thrombus burden in a patient with PCV…
View more
Author(s):
Sonika Malik
,
Anju Bhardwaj
,
Matthew Eisen
,
et al
Added:
3 years ago
Pulmonary embolism (PE) is a common and serious manifestation of venous thromboembolism (VTE) and is an important cause of morbidity and mortality in the US. The incidence is estimated to be 50 per 100,000 but increases to 500 per 100,000 in the elderly.1 There is a wide spectrum of clinical severity with mortality estimates of 1–2 % in stable individuals and up to 30 % in patients presenting…
View more
The US Cardiovascular Arena In Brief—A Round-up of Trends, Statistics, and Clinical Research
Added:
3 years ago
Article
Author(s):
Muhammad Asim Shabbir
,
Pradeep Yadav
,
Nidhish Tiwari
,
et al
Added:
8 months ago
Author(s):
A Bajpai
,
A John Camm
,
I Savelieva
Added:
3 years ago
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is characterized by unco-ordinated atrial activation with consequent loss of atrial mechanical function. In developed nations, the number of men and women affected by AF is projected to more than double over the next two decades. Despite major advances in its management, AF remains a significant cause of cardiovascular…
View more
Author(s):
Jason Chinitz
,
Dorinna D Mendoza
,
Raymond J Kim
,
et al
Added:
3 years ago
Accurate detection of left ventricular (LV) thrombus affects clinical outcomes and therapeutic management, as thrombus provides a substrate for thromboembolic events and a rationale for anticoagulation. Relative risk (RR) for thrombus development is highest among subjects with systolic heart failure or myocardial infarction (MI), reflecting a link between impaired LV blood stasis, pro-coagulant…
View more
Author(s):
Paolo Della Bella
Added:
2 years ago
In this short interview from ACC.22, Dr Paolo Della Bella (San Raffaele University-Hospital, IT) joins us to discuss the findings of the PARTITA trial (NCT01547208). The aim of this study was to determine whether the burden of ventricular tachycardia correlates with ICD shock therapies and if the timing of VT ablation affects patient prognosis.
Discussion Points:
Rationale behind this trial
…
View more
Author(s):
Birgit Vogel
,
Harriette Van Spall
Added:
2 years ago
In the ESC Congress 2021 episode of the Masterclass video series, host, Dr Harriette Van Spall (McMaster University, CA) meets with Dr Birgit Vogel (Icahn School of Medicine at Mount Sinai, US), one of the commissioners and first author of the "The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030" report.Dr Vogel talks about the rationale of the report. CV…
View more
Foreword
Author(s):
Donald E Cutlip
Added:
3 years ago
Article
Author(s):
On Topaz
Added:
3 years ago
The last three years have seen the application of percutaneous excimer laser atherectomy in patients sustaining acute myocardial infarction (AMI) gaining momentum. Current efforts in the US are concentrated toward identification of the best technologies for efficacious restoration of flow in the infarct-related vessel and toward shortening the time lag between the presentation of AMI patients to…
View more